JG

Jernej Godec

Biotech Venture Capital

Cambridge, Massachusetts

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $10,000,000.00

  • Max Investment:

    $50,000,000.00

  • Target Investment:

    $25,000,000.00

Skills

Molecular Biology
Flow Cytometry
Cell Culture
Western Blotting
Tissue Culture
Cell Biology
ELISA
Molecular Cloning
In Vitro
qPCR
Laboratory
Microbiology
Fluorescence Microscopy
Oncology
Immunology
Student Leadership

Education

Investments

Diagonal Therapeutics

Series A

Total Funding: $130M

Work Experience

Atlas Venture

2019

  • Principal

    2021

  • Senior Associate

    2021 - 2021

  • Associate

    2019 - 2021

Apple Tree Partners

2016 - 2019

  • Senior Associate

    2019 - 2019

  • Associate

    2016 - 2019

Elstar Therapeutics Inc.

2017 - 2019

  • Board Observer

    2017 - 2019

  • Director, Business Development and Corporate Strategy

    2017 - 2019

MIFCOR, Inc.

2014 - 2017

  • Co-Founder, Head of R&D

    2014 - 2017

    Biotech startup developing a first-in-class drugs for ischemia-reperfusion injury.

Harvard University

2010 - 2016

  • Graduate Researcher and Postdoctoral Fellow

    2010 - 2016

    Haining Lab, Department of Pediatric Oncology, Dana-Farber Cancer Institute. Sharpe Lab, Department of Microbiology and Immunobiology, Harvard Medical School.

Flagship Ventures

2015 - 2016

  • VentureLabs Fellow and Consultant

    2015 - 2016

UC Berkeley

2006 - 2010

  • Staff Research Associate

    2008 - 2010

    Barton Lab, Division of Immunology and Pathogenesis, Department of Molecular and Cell Biology.

  • Tutor/Study Group Facilitator

    2006 - 2009

    Athletic Study Center.

Dynavax Technologies

2007 - 2007

  • Research Assistant - Intern

    2007 - 2007